Your browser doesn't support javascript.
loading
Safety of dermatologic medications in pregnancy and lactation: An update - Part I: Pregnancy.
McMullan, Patrick; Yaghi, Marita; Truong, Thu M; Rothe, Marti; Murase, Jenny; Grant-Kels, Jane M.
Afiliação
  • McMullan P; Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut.
  • Yaghi M; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami, Miller School of Medicine, Miami, Florida.
  • Truong TM; School of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey; Center for Dermatology, Rutgers Robert Wood Johnson Medical School, Somerset, New Jersey.
  • Rothe M; Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut.
  • Murase J; Department of Dermatology, University of California, San Francisco, California; Palo Alto Foundation Medical Group, Mountain View, California.
  • Grant-Kels JM; Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut; Department of Dermatology, University of Florida, Gainesville, Florida. Electronic address: grant@uchc.edu.
J Am Acad Dermatol ; 91(4): 619-648, 2024 Oct.
Article em En | MEDLINE | ID: mdl-38280679
ABSTRACT
The breadth of therapeutic options for the management of dermatologic skin conditions continues to expand rapidly as exemplified by biologics and small molecule drug development. While dermatologists and health care providers are aware of the underlying mechanisms and indications for these therapeutics, there is a recognized practice gap due to an incomplete understanding of the safety of these medications in women of childbearing age during the prepartum, antepartum, and postpartum phases. Although a two-part continuing medical education review was published regarding the prescribing practices and safety profiles of these new therapeutics in women of childbearing age while pregnant or lactating in 2014, many new medications have been approved since then. Herein, we will update the safety of dermatologic therapies during pregnancy and Part II will review the safety of medications during lactation.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações na Gravidez / Dermatopatias / Lactação / Fármacos Dermatológicos Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações na Gravidez / Dermatopatias / Lactação / Fármacos Dermatológicos Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2024 Tipo de documento: Article